Format

Send to

Choose Destination
JAAD Case Rep. 2019 Jan 30;5(2):170-172. doi: 10.1016/j.jdcr.2018.11.021. eCollection 2019 Feb.

Disappearing pigmentary mosaicism during imatinib treatment for gastrointestinal stromal tumors.

Author information

1
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
2
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
3
Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.

KEYWORDS:

GIST, gastrointestinal stromal tumor; c-kit; gastrointestinal stromal tumors; imatinib; pigmentary mosaicism

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center